A single centre service evaluation of 53 MRONJ cases
Medication-related osteonecrosis of the jaw (MRONJ) is a significant complication associated with antiresorptive or antiangiogenic medications, particularly bisphosphonates and denosumab, commonly used in the management of osteoporosis and metastatic bone disease.This retrospective service evaluatio...
Saved in:
| Main Authors: | Millicent Forrest, Sanford Grossman, Noha Seoudi, Edmund Bailey, Rishi Bhandari, Leo Cheng, Judith Jones, Zoe Killick, Mohammed Dungarwalla |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Advances in Oral and Maxillofacial Surgery |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667147625000433 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium
by: Vittorio Fusco, et al.
Published: (2025-04-01) -
Awareness and Attitude Towards MRONJ Among Physicians Prescribing Antiresorptive Drugs: A Cross-Sectional Study
by: Murat Mutlu, et al.
Published: (2025-07-01) -
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS
by: Francesco Bertoldo, et al.
Published: (2025-02-01) -
Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
by: Miika Kujanpää, et al.
Published: (2025-05-01) -
The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
by: Filip Michalak, et al.
Published: (2025-01-01)